Biology of GDNF and its receptors — Relevance for disorders of the central nervous system

Neurobiology of Disease

Volumn 97, Issue , 2017, Pages 80-89

  Ibáñez, Carlos F ^a,b,c   Andressoo, Jaan Olle ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

GDNF; Neuropsychiatric disorders; Parkinson's disease

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; NERVE GROWTH FACTOR RECEPTOR;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; DOPAMINE BRAIN LEVEL; EPILEPSY; EXERCISE; HIPPOCAMPUS; HUMAN; MENTAL DISEASE; MICROGLIA; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYNAPTOGENESIS; ANIMAL; METABOLISM;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; RECEPTORS, NERVE GROWTH FACTOR;

EID: 84957079834     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.01.021     Document Type: Review

References (153)

1. Airaksinen, M.S., Saarma, M., The GDNF Family: Signalling, Biological Functions and Therapeutic Value. 3, 2002, 383–394.
2. Alvarez, P., Chen, X., Bogen, O., Green, P.G., Levine, J.D., IB4(+) nociceptors mediate persistent muscle pain induced by GDNF. J. Neurophysiol. 108 (2012), 2545–2553.
3. Arenas, E., Trupp, M., Akerud, P., Ibanez, C.F., GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15 (1995), 1465–1473.
4. Barbosa, I.G., Huguet, R.B., Sousa, L.P., Abreu, M.N.S., Rocha, N.P., Bauer, M.E., Carvalho, L.A., Teixeira, A.L., Circulating levels of GDNF in bipolar disorder. Neurosci. Lett. 502 (2011), 103–106.
5. Bartolini, G., Ciceri, G., Marín, O., Integration of GABAergic interneurons into cortical cell assemblies: lessons from embryos and adults. Neuron 79 (2013), 849–864.
6. Baudet, C., Mikaels, A., Westphal, H., Johansen, J., Johansen, T.E., Ernfors, P.P., Positive and negative interactions of GDNF, NTN and ART in developing sensory neuron subpopulations, and their collaboration with neurotrophins. Development 127 (2000), 4335–4344.
7. Baudet, C., Pozas, E., Adameyko, I., Andersson, E., Ericson, J., Ernfors, P.P., Retrograde signaling onto Ret during motor nerve terminal maturation. J. Neurosci. 28 (2008), 963–975.
8. Beck, K.D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R.A., Rosenthal, A., Hefti, F., Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373 (1995), 339–341.
9. Bespalov, M.M., Sidorova, Y.A., Tumova, S., Ahonen-Bishopp, A., Magalhães, A.C., Kulesskiy, E., Paveliev, M., Rivera, C., Rauvala, H., Saarma, M., Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin. J. Cell Biol. 192 (2011), 153–169.
10. Björklund, A., Dunnett, S.B., Fifty years of dopamine research. Trends Neurosci. 30 (2007), 185–187.
11. Björklund, A., Dunnett, S.B., Dopamine neuron systems in the brain: an update. Trends Neurosci. 30 (2007), 194–202.
12. Boger, H.A., Boger, H.A., Middaugh, L.D., Huang, P., Zaman, V., Smith, A.C., Hoffer, B.J., Tomac, A.C., Granholm, A.-C., A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp. Neurol. 202 (2006), 336–347.
13. Bonanomi, D., Chivatakarn, O., Bai, G., Abdesselem, H., Lettieri, K., Marquardt, T., Pierchala, B.A., Pfaff, S.L., Ret is a multifunctional coreceptor that integrates diffusible- and contact-axon guidance signals. Cell 148 (2012), 568–582.
14. Bondareff, W., Mountjoy, C.Q., Roth, M., Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32 (1982), 164–168.
15. Borrione, P., Effects of physical activity in Parkinson's disease: a new tool for rehabilitation. WJM, 4, 2014, 133.
16. Burke, R.E., Postnatal developmental programmed cell death in dopamine neurons. Ann. N. Y. Acad. Sci. 991 (2003), 69–79.
17. Burke, R.E., O'Malley, K., Axon degeneration in Parkinson's disease. Exp. Neurol. 246 (2013), 72–83.
18. Cacalano, G., Fariñas, I., Wang, L.C., Hagler, K., Forgie, A., Moore, M., Armanini, M.P., Phillips, H.S., Ryan, A.M., Reichardt, L.F., et al. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21 (1998), 53–62.
19. Canty, A.J., Dietze, J., Harvey, M., Enomoto, H., Milbrandt, J., Ibanez, C.F., Regionalized loss of parvalbumin interneurons in the cerebral cortex of mice with deficits in GFRalpha1 signaling. J. Neurosci. 29 (2009), 10695–10705.
20. Carnicella, S., Ron, D., GDNF—a potential target to treat addiction. Pharmacol. Ther. 122 (2009), 9–18.
21. Carnicella, S., Kharazia, V., Jeanblanc, J., Janak, P.H., Ron, D., GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 8114–8119.
22. Carnicella, S., Ahmadiantehrani, S., Janak, P.H., Ron, D., GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence. Alcohol. Clin. Exp. Res. 33 (2009), 1012–1024.
23. Charoy, C., Nawabi, H., Reynaud, F., Derrington, E., Bozon, M., Wright, K., Falk, J., Helmbacher, F., Kindbeiter, K., Castellani, V., Gdnf activates midline repulsion by Semaphorin3B via NCAM during commissural axon guidance. Neuron 75 (2012), 1051–1066.
24. Cohen, A.D., Tillerson, J.L., Smith, A.D., Schallert, T., Zigmond, M.J., Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J. Neurochem. 85 (2003), 299–305.
25. Diniz, B.S., Teixeira, A.L., Miranda, A.S., Talib, L.L., Gattaz, W.F., Forlenza, O.V., Circulating glial-derived neurotrophic factor is reduced in late-life depression. J. Psychiatr. Res. 46 (2012), 135–139.
26. Duarte, E.P., Curcio, M., Canzoniero, L.M., Duarte, C.B., Neuroprotection by GDNF in the ischemic brain. Growth Factors 30 (2012), 242–257.
27. Duveau, V., Fritschy, J.-M., PSA-NCAM-dependent GDNF signaling limits neurodegeneration and epileptogenesis in temporal lobe epilepsy. Eur. J. Neurosci. 32 (2010), 89–98.
28. Emerich, D.F., Plone, M., Francis, J., Frydel, B.R., Winn, S.R., Lindner, M.D., Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts. Brain Res. 736 (1996), 99–110.
29. Enomoto, H., Araki, T., Jackman, A., Heuckeroth, R.O., Snider, W.D., Johnson, E.M., Milbrandt, J., GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 21 (1998), 317–324.
30. Euteneuer, S., Yang, K.H., Chavez, E., Leichtle, A., Loers, G., Olshansky, A., Pak, K., Schachner, M., Ryan, A.F., Glial cell line-derived neurotrophic factor (GDNF) induces neuritogenesis in the cochlear spiral ganglion via neural cell adhesion molecule (NCAM). Mol. Cell. Neurosci. 54 (2013), 30–43.
31. Exner, N., Lutz, A.K., Haass, C., Winklhofer, K.F., Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J. 31 (2012), 3038–3062.
32. Fontenelle, L.F., Barbosa, I.G., Luna, J.V., Rocha, N.P., Silva Miranda, A., Teixeira, A.L., Neurotrophic factors in obsessive–compulsive disorder. Psychiatry Res. 199 (2012), 195–200.
33. Fundin, B.T., Mikaels, A., Westphal, H., Ernfors, P.P., A rapid and dynamic regulation of GDNF-family ligands and receptors correlate with the developmental dependency of cutaneous sensory innervation. Development 126 (1999), 2597–2610.
34. Gant, J.C., Thibault, O., Blalock, E.M., Yang, J., Bachstetter, A., Kotick, J., Schauwecker, P.E., Hauser, K.F., Smith, G.M., Mervis, R., et al. Decreased Number of Interneurons and Increased Seizures in Neuropilin 2 Deficient Mice: Implications for Autism and Epilepsy. 50, 2009, 629–645.
35. Gash, D.M., Zhang, Z., Ovadia, A., Cass, W.A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P.A., Collins, F., et al. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380 (1996), 252–255.
36. Georgievska, B., Kirik, D., Björklund, A., Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 177 (2002), 461–474.
37. Georgievska, B., Kirik, D., Björklund, A., Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. J. Neurosci. 24 (2004), 6437–6445.
38. Gill, S.S., Patel, N.K., Hotton, G.R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D.J., Svendsen, C.N., Heywood, P., Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9 (2003), 589–595.
39. Godar, S.C., Mosher, L.J., Di Giovanni, G., Bortolato, M., Animal models of tic disorders: a translational perspective. J. Neurosci. Methods 238 (2014), 54–69.
40. Golden, J.P., DeMaro, J.A., Osborne, P.A., Milbrandt, J., Johnson, E.M., Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse. Exp. Neurol. 158 (1999), 504–528.
41. Gould, T.W., Yonemura, S., Oppenheim, R.W., Ohmori, S., Enomoto, H., The neurotrophic effects of glial cell line-derived neurotrophic factor on spinal motoneurons are restricted to fusimotor subtypes. J. Neurosci. 28 (2008), 2131–2146.
42. Granholm, A.-C., Zaman, V., Godbee, J., Smith, M., Ramadan, R., Umphlet, C., Randall, P., Bhat, N.R., Rohrer, B., Middaugh, L.D., et al. Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathol. 21 (2011), 330–348.
43. Haase, G., Dessaud, E., Garces, A., de Bovis, B., Birling, M., Filippi, P., Schmalbruch, H., Arber, S., Delapeyrière, O., GDNF acts through PEA3 to regulate cell body positioning and muscle innervation of specific motor neuron pools. Neuron 35 (2002), 893–905.
44. Hebert, M.A., Gerhardt, G.A., Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J. Pharmacol. Exp. Ther. 282 (1997), 760–768.
45. Hebert, M.A., Van Horne, C.G., Hoffer, B.J., Gerhardt, G.A., Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J. Pharmacol. Exp. Ther. 279 (1996), 1181–1190.
46. Henderson, C.E., Phillips, H.S., Pollock, R.A., Davies, A.M., LEMEULLE, C., Armanini, M., Simmons, L., MOFFET, B., Vandlen, R.A., Simmons, L., et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266 (1994), 1062–1064.
47. Hidalgo-Figueroa, M., Bonilla, S., Gutiérrez, F., Pascual, A., López-Barneo, J., GDNF is predominantly expressed in the PV + neostriatal interneuronal ensemble in normal mouse and after injury of the nigrostriatal pathway. J. Neurosci. 32 (2012), 864–872.
48. Hoffer, B.J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L.F., Gerhardt, G.A., Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182 (1994), 107–111.
49. Hudson, J., Granholm, A.C., Gerhardt, G.A., Henry, M.A., Hoffman, A., Biddle, P., Leela, N.S., Mackerlova, L., Lile, J.D., Collins, F., Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36 (1995), 425–432.
50. Huertas-Fernández, I., Gómez-Garre, P., Madruga-Garrido, M., Bernal-Bernal, I., Bonilla-Toribio, M., Martín-Rodríguez, J.F., Cáceres-Redondo, M.T., Vargas-González, L., Carrillo, F., Pascual, A., et al. GDNF gene is associated with tourette syndrome in a family study. Mov. Disord. 30 (2015), 1115–1120.
51. Hunot, S., Bernard, V., Faucheux, B., Boissière, F., Leguern, E., Brana, C., Gautris, P.P., Guérin, J., Bloch, B., Agid, Y., et al. Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease. J. Neural Transm. (Vienna) 103 (1996), 1043–1052.
52. Ibanez, C.F., Catecholaminergic neuron survival: getting hooked on GDNF. Nat. Neurosci. 11 (2008), 735–736.
53. Ibanez, C.F., Beyond the cell surface: new mechanisms of receptor function. Biochem. Biophys. Res. Commun. 396 (2010), 24–27.
54. Ibanez, C.F., Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harb. Perspect. Biol. 5 (2013), 1–10.
55. Jain, S., Golden, J.P., Wozniak, D., Pehek, E., Johnson, E.M., Milbrandt, J., RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice. J. Neurosci. 26 (2006), 11230–11238.
56. Jing, S., Wen, D., Yu, Y., Holst, P.L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85 (1996), 1113–1124.
57. Kalanithi, P.S.A., Zheng, W., Kataoka, Y., DiFiglia, M., Grantz, H., Saper, C.B., Schwartz, M.L., Leckman, J.F., Vaccarino, F.M., Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 13307–13312.
58. Kanter-Schlifke, I., Fjord-Larsen, L., Kusk, P., Angehagen, M., Wahlberg, L., Kokaia, M., GDNF released from encapsulated cells suppresses seizure activity in the epileptic hippocampus. Exp. Neurol. 216 (2009), 413–419.
59. Kholodilov, N., Yarygina, O., Oo, T.F., Zhang, H., Sulzer, D., Dauer, W., Burke, R.E., Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets. J. Neurosci. 24 (2004), 3136–3146.
60. Kholodilov, N., Kim, S.R., Yarygina, O., Kareva, T., Cho, J.W., Baohan, A., Burke, R.E., Glial cell line-derived neurotrophic factor receptor-α1 expressed in striatum in trans regulates development and injury response of dopamine neurons of the substantia nigra. J. Neurochem. 116 (2011), 486–498.
61. Kirik, D., Rosenblad, C., Bjorklund, A., Mandel, R.J., Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J. Neurosci. 20 (2000), 4686–4700.
62. Kirik, D., Georgievska, B., Björklund, A., Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nature 7 (2004), 105–110.
63. Kobayashi, T., Ahlenius, H., Thored, P., Kobayashi, R., Kokaia, Z., Lindvall, O., Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke 37 (2006), 2361–2367.
64. Kopra, J., Vilenius, C., Grealish, S., Härma, M.-A., Varendi, K., Lindholm, J., Castrén, E., Võikar, V., Björklund, A., Piepponen, T.P., et al. GDNF is not required for catecholaminergic neuron survival in vivo. Nat. Neurosci. 18 (2015), 319–322.
65. Kotyuk, E., Keszler, G., Nemeth, N., Ronai, Z., Sasvari-Szekely, M., Szekely, A., Glial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxiety. PLoS One, 8, 2013, e80613.
66. Krakora, D., Mulcrone, P., Meyer, M., Lewis, C., Bernau, K., Gowing, G., Zimprich, C., Aebischer, P., Svendsen, C.N., Suzuki, M., Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model. Mol. Ther. 21 (2013), 1602–1610.
67. Kramer, E.R., Knott, L., Su, F., Dessaud, E., Krull, C.E., Helmbacher, F., Klein, R., Cooperation between GDNF/Ret and ephrinA/EphA4 signals for motor-axon pathway selection in the limb. Neuron 50 (2006), 35–47.
68. Kramer, Aron, Ramakers, L., Seitz, Zhuang, Beyer, Smidt, Klein, Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system. PLoS Biol., 5, 2007, e39.
69. Kumar, A., Kopra, J., Saarma, M., Andressoo, J.-O., Andress, Overexpression from the native locus reveals its role in the nigrostriatal dopaminergic system function. PLoS Genet, 2015.
70. Lang, A.E., Gill, S., Patel, N.K., Lozano, A., Nutt, J.G., Penn, R., Brooks, D.J., Hotton, G., Moro, E., Heywood, P., et al. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol. 59 (2006), 459–466.
71. Ledda, F., Ligand-induced cell adhesion as a new mechanism to promote synapse formation. Cell Adhes. Migr. 1 (2007), 137–139.
72. Ledda, F., Paratcha, G., Ibanez, C.F., Target-derived GFRalpha1 as an attractive guidance signal for developing sensory and sympathetic axons via activation of Cdk5. Neuron 36 (2002), 387–401.
73. Ledda, F., Paratcha, G., Sandoval-Guzmán, T., Ibanez, C.F., GDNF and GFRalpha1 promote formation of neuronal synapses by ligand-induced cell adhesion. Nat. Neurosci. 10 (2007), 293–300.
74. Lee, B.-H., Hong, J.-P., Hwang, J.-A., Na, K.-S., Kim, W.-J., Trigo, J., Kim, Y.-K., Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder: a preliminary study. Acta Neuropsychiatr., 2015, 1–6.
75. Lin, P.-Y., Tseng, P.-T., Decreased glial cell line-derived neurotrophic factor levels in patients with depression: a meta-analytic study. J. Psychiatr. Res. 63 (2015), 20–27.
76. Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S., Collins, F., GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260 (1993), 1130–1132.
77. Lippoldt, E.K., Elmes, R.R., McCoy, D.D., Knowlton, W.M., McKemy, D.D., Artemin, a glial cell line-derived neurotrophic factor family member, induces TRPM8-dependent cold pain. J. Neurosci. 33 (2013), 12543–12552.
78. Lodge, D.J., Behrens, M.M., Grace, A.A., A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J. Neurosci. 29 (2009), 2344–2354.
79. Love, S., Plaha, P., Patel, N.K., Hotton, G.R., Brooks, D.J., Gill, S.S., Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat. Med. 11 (2005), 703–704.
80. Ma, X.-C., Chen, C., Zhu, F., Jia, W., Gao, C.-G., Association of the GDNF gene with depression and heroin dependence, but not schizophrenia, in a Chinese population. Psychiatry Res. 210 (2013), 1296–1298.
81. Manfredsson, F.P., Tumer, N., Erdos, B., Landa, T., Broxson, C.S., Sullivan, L.F., Rising, A.C., Foust, K.D., Zhang, Y., Muzyczka, N., et al. Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity. Mol. Ther. 17 (2009), 980–991.
82. Marks, C., Belluscio, L., Ibanez, C.F., Critical role of GFRα1 in the development and function of the main olfactory system. J Neurosci 32 (2012), 17306–17320.
83. Martin, D., Miller, G., Rosendahl, M., Russell, D.A., Potent inhibitory effects of glial derived neurotrophic factor against kainic acid mediated seizures in the rat. Brain Res. 683 (1995), 172–178.
84. Matsuda, W., Furuta, T., Nakamura, K.C., Hioki, H., Fujiyama, F., Arai, R., Kaneko, T., Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J. Neurosci. 29 (2009), 444–453.
85. McCullough, M.J., Gyorkos, A.M., Spitsbergen, J.M., Short-term exercise increases GDNF protein levels in the spinal cord of young and old rats. Neuroscience 240 (2013), 258–268.
86. Meissner, W.G., Frasier, M., Gasser, T., Goetz, C.G., Lozano, A., Piccini, P., Obeso, J.A., Rascol, O., Schapira, A., Voon, V., et al. Priorities in Parkinson's disease research. Nat. Rev. Drug Discov. 10 (2011), 377–393.
87. Meka, D.P., Müller-Rischart, A.K., Nidadavolu, P., Mohammadi, B., Motori, E., Ponna, S.K., Aboutalebi, H., Bassal, M., Annamneedi, A., Finckh, B., et al. Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration. J. Clin. Invest. 125 (2015), 1873–1885.
88. Meng, X., Lindahl, M., Hyvönen, M.E., Parvinen, M., de Rooij, D.G., Hess, M.W., Raatikainen-Ahokas, A., Sainio, K., Rauvala, H., Lakso, M., et al. Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science 287 (2000), 1489–1493.
89. Messer, C.J., Eisch, A.J., Carlezon, W.A., Whisler, K., Shen, L., Wolf, D.H., Westphal, H., Collins, F., Russell, D.S., Nestler, E.J., Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26 (2000), 247–257.
90. Mijatovic, J., Airavaara, M., Planken, A., Auvinen, P., Raasmaja, A., Piepponen, T.P., Costantini, F., Ahtee, L., Saarma, M., Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra. J. Neurosci. 27 (2007), 4799–4809.
91. Mijatovic, J., Patrikainen, O., Yavich, L., Airavaara, M., Ahtee, L., Saarma, M., Piepponen, T.P., Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine. J. Neurochem. 105 (2008), 1716–1725.
92. Mijatovic, J., Piltonen, M., Alberton, P., Männistö, P.T., Saarma, M., Piepponen, T.P., Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals. Neurobiol. Aging 32 (2011), 1486–1494.
93. Moises, H.W., Zoega, T., Gottesman, I.I., The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry, 2, 2002, 8.
94. Moore, M.W., Klein, R.D., Fariñas, I., Sauer, H., Armanini, M., Phillips, H., Reichardt, L.F., Ryan, A.M., Carver-Moore, K., Rosenthal, A., Renal and neuronal abnormalities in mice lacking GDNF. Nature 382 (1996), 76–79.
95. Nanobashvili, A., Airaksinen, M.S., Kokaia, M., Rossi, J., Asztély, F., Olofsdotter, K., Mohapel, P., Saarma, M., Lindvall, O., Kokaia, Z., Development and persistence of kindling epilepsy are impaired in mice lacking glial cell line-derived neurotrophic factor family receptor alpha 2. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 12312–12317.
96. Naumenko, V.S., Bazovkina, D.V., Semenova, A.A., Tsybko, A.S., Il'chibaeva, T.V., Kondaurova, E.M., Popova, N.K., Effect of glial cell line-derived neurotrophic factor on behavior and key members of the brain serotonin system in mouse strains genetically predisposed to behavioral disorders. J. Neurosci. Res. 91 (2013), 1628–1638.
97. Nielsen, J., Gotfryd, K., Li, S., Kulahin, N., Soroka, V., Rasmussen, K.K., Bock, E., Berezin, V., Role of glial cell line-derived neurotrophic factor (GDNF)-neural cell adhesion molecule (NCAM) interactions in induction of neurite outgrowth and identification of a binding site for NCAM in the heel region of GDNF. J. Neurosci. 29 (2009), 11360–11376.
98. Ohnaka, M., Miki, K., Gong, Y.-Y., Stevens, R., Iwase, T., Hackett, S.F., Campochiaro, P.A., Long-term expression of glial cell line-derived neurotrophic factor slows, but does not stop retinal degeneration in a model of retinitis pigmentosa. J. Neurochem. 122 (2012), 1047–1053.
99. Oo, T.F., Ries, V., Cho, J., Kholodilov, N., Burke, R.E., Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat. J. Comp. Neurol. 484 (2005), 57–67.
100. Oppenheim, R.W., Houenou, L.J., Parsadanian, A.S., Prevette, D., Snider, W.D., Shen, L., Glial cell line-derived neurotrophic factor and developing mammalian motoneurons: regulation of programmed cell death among motoneuron subtypes. J. Neurosci. 20 (2000), 5001–5011.
101. Paratcha, G., Ibanez, C.F., Lipid rafts and the control of neurotrophic factor signaling in the nervous system: variations on a theme. Curr. Opin. Neurobiol. 12 (2002), 542–549.
102. Paratcha, G., Ledda, F., GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends Neurosci. 31 (2008), 384–391.
103. Paratcha, G., Ledda, F., Baars, L., Coulpier, M., Besset, V., Besset, V., Anders, J., Scott, R., Ibanez, C.F., Released GFRalpha1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 29 (2001), 171–184.
104. Paratcha, G., Ledda, F., Ibanez, C.F., The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 113 (2003), 867–879.
105. Paratcha, G., Ibanez, C.F., Ledda, F., GDNF is a chemoattractant factor for neuronal precursor cells in the rostral migratory stream. Mol. Cell. Neurosci. 31 (2006), 505–514.
106. Parish, C.L., Finkelstein, D.I., Drago, J., Borrelli, E., Horne, M.K., The role of dopamine receptors in regulating the size of axonal arbors. J. Neurosci. 21 (2001), 5147–5157.
107. Pascual, A., Hidalgo-Figueroa, M., Piruat, J.I., Pintado, C.O., Gómez-Díaz, R., López-Barneo, J., Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat. Neurosci. 11 (2008), 755–761.
108. Patel, N.K., Bunnage, M., Plaha, P., Svendsen, C.N., Heywood, P., Gill, S.S., Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann. Neurol. 57 (2005), 298–302.
109. Perrinjaquet, M., Sjöstrand, D., Moliner, A., Zechel, S., Lamballe, F., Maina, F., Ibanez, C.F., MET signaling in GABAergic neuronal precursors of the medial ganglionic eminence restricts GDNF activity in cells that express GFRα1 and a new transmembrane receptor partner. J. Cell Sci. 124 (2011), 2797–2805.
110. Pichel, J.G., Shen, L., Sheng, H.Z., Granholm, A.C., Drago, J., Grinberg, A., Lee, E.J., Huang, S.P., Saarma, M., Hoffer, B.J., et al. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382 (1996), 73–76.
111. Pozas, E., Ibanez, C.F., GDNF and GFRalpha1 promote differentiation and tangential migration of cortical GABAergic neurons. Neuron 45 (2005), 701–713.
112. Pruett, B.S., Salvatore, M.F., Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity. Mol. Neurobiol. 47 (2013), 988–999.
113. Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L.F., Galasko, D.R., Jutel, M., Karydas, A., et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13 (2007), 1359–1362.
114. Reeben, M., Laurikainen, A., Hiltunen, J.O., Castren, E., Saarma, M., The messenger RNAs for both glial cell line-derived neurotrophic factor receptors, c-ret and GDNFRalpha, are induced in the rat brain in response to kainate-induced excitation. Neuroscience 83 (1998), 151–159.
115. Rocha, S.M., Cristovão, A.C., Campos, F.L., Fonseca, C.P., Baltazar, G., Astrocyte-derived GDNF is a potent inhibitor of microglial activation. Neurobiol. Dis. 47 (2012), 407–415.
116. Rosenblad, C., Georgievska, B., Kirik, D., Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system. Eur. J. Neurosci. 17 (2003), 260–270.
117. Rossi, J., Luukko, K., Poteryaev, D., Laurikainen, A., Sun, Y.F., Laakso, T., Eerikäinen, S., Tuominen, R., Lakso, M., Rauvala, H., et al. Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR alpha2, a functional neurturin receptor. Neuron 22 (1999), 243–252.
118. Sainio, K., Suvanto, P., Davies, J.A., Wartiovaara, J., Wartiovaara, K., Saarma, M., Arumae, U., Meng, X., Lindahl, M., Pachnis, V., et al. Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 124 (1997), 4077–4087.
119. Sakai, A., Asada, M., Seno, N., Suzuki, H., Involvement of neural cell adhesion molecule signaling in glial cell line-derived neurotrophic factor-induced analgesia in a rat model of neuropathic pain. Pain 137 (2008), 378–388.
120. Sakai, T., Oshima, A., Nozaki, Y., Ida, I., Haga, C., Akiyama, H., Nakazato, Y., Mikuni, M., Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 28 (2008), 143–150.
121. Sánchez, M.P., Silos-Santiago, I., Frisén, J., He, B., Lira, S.A., Barbacid, M., Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382 (1996), 70–73.
122. Savitt, J., Singh, D., Zhang, C., Chen, L.-C., Folmer, J., Shokat, K.M., Wright, W.W., The in vivo response of stem and other undifferentiated spermatogonia to the reversible inhibition of glial cell line-derived neurotrophic factor signaling in the adult. Stem Cells 30 (2012), 732–740.
123. Scholz, D., Chernyshova, Y., Leist, M., Control of Aβ release from human neurons by differentiation status and RET signaling. Neurobiol. Aging 34 (2013), 184–199.
124. Shakya, R., Watanabe, T., Costantini, F.D., The role of GDNF/Ret signaling in ureteric bud cell fate and branching morphogenesis. Dev. Cell 8 (2005), 65–74.
125. Sherer, T.B., Fiske, B.K., Svendsen, C.N., Lang, A.E., Langston, J.W., Crossroads in GDNF therapy for Parkinson's disease. Mov. Disord. 21 (2006), 136–141.
126. Shim, S.-H., Hwangbo, Y., Yoon, H.-J., Kwon, Y.-J., Lee, H.-Y., Hwang, J.-A., Kim, Y.-K., Increased levels of plasma glial-derived neurotrophic factor in children with attention deficit hyperactivity disorder. Nord. J. Psychiatry 69 (2015), 1–6.
127. Shimizu, F., Sano, Y., Saito, K., Abe, M.-A., Maeda, T., Haruki, H., Kanda, T., Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood–brain barrier and the blood-nerve barrier. Neurochem. Res. 37 (2012), 401–409.
128. Sjöstrand, D., Ibanez, C.F., Insights into GFRalpha1 regulation of neural cell adhesion molecule (NCAM) function from structure–function analysis of the NCAM/GFRalpha1 receptor complex. J. Biol. Chem. 283 (2008), 13792–13798.
129. Sjöstrand, D., Carlsson, J., Paratcha, G., Persson, B., Ibanez, C.F., Disruption of the GDNF binding site in NCAM dissociates ligand binding and homophilic cell adhesion. J. Biol. Chem. 282 (2007), 12734–12740.
130. Suarez, B.K., Duan, J., Sanders, A.R., Hinrichs, A.L., Jin, C.H., Hou, C., Buccola, N.G., Hale, N., Weilbaecher, A.N., Nertney, D.A., et al. Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3–p21.2 and 11p13.1–q14.1 in the combined sample. Am. J. Hum. Genet. 78 (2006), 315–333.
131. Syed, Z., Dudbridge, F., Kent, L., An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B (2007), 375–378.
132. Tabuchi, K., Blundell, J., Etherton, M.R., Hammer, R.E., Liu, X., Powell, C.M., Südhof, T.C., A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318 (2007), 71–76.
133. Taraviras, S., Marcos-Gutierrez, C.V., Durbec, P., Jani, H., Grigoriou, M., Sukumaran, M., Wang, L.C., Hynes, M.A., Raisman, G., Pachnis, V., Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development 126 (1999), 2785–2797.
134. Tomac, A., Lindqvist, E., Lin, L.F., Ogren, S.O., Young, D., Hoffer, B.J., Olson, L., Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373 (1995), 335–339.
135. Tomlinson, B.E., Irving, D., Blessed, G., Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J. Neurol. Sci. 49 (1981), 419–428.
136. Trupp, M., Rydén, M., Jörnvall, H., Funakoshi, H., Timmusk, T., Arenas, E., Ibanez, C.F., Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130 (1995), 137–148.
137. Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A.S., Sieber, B.A., Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V., Arumae, U., et al. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381 (1996), 785–789.
138. Trupp, M., Belluardo, N., Funakoshi, H., Ibanez, C.F., Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17 (1997), 3554–3567.
139. Trupp, M., Raynoschek, C., Belluardo, N., Ibanez, C.F., Multiple GPI-anchored receptors control GDNF-dependent and independent activation of the c-Ret receptor tyrosine kinase. Mol. Cell. Neurosci. 11 (1998), 47–63.
140. Tseng, P.-T., Lee, Y., Lin, P.-Y., Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 40 (2013), 334–339.
141. Tsui, C.C., Gabreski, N.A., Hein, S.J., Pierchala, B.A., Lipid rafts are physiologic membrane microdomains necessary for the morphogenic and developmental functions of glial cell line-derived neurotrophic factor in vivo. J. Neurosci. 35 (2015), 13233–13243.
142. Tunca, Z., Kıvırcık Akdede, B., Özerdem, A., Alkın, T., Polat, S., Ceylan, D., Bayın, M., Cengizçetin Kocuk, N., Şimşek, S., Resmi, H., et al. Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: a comparative study in four major psychiatric disorders. Eur. Psychiatry 30 (2015), 198–204.
143. Ubhi, K., Inglis, C., Mante, M., Patrick, C., Adame, A., Spencer, B., Rockenstein, E., May, V., Winkler, J., Masliah, E., Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy. Exp. Neurol. 234 (2012), 405–416.
144. Wan, G., Too, H.-P., A specific isoform of glial cell line-derived neurotrophic factor family receptor alpha 1 regulates RhoA expression and glioma cell migration. J. Neurochem. 115 (2010), 759–770.
145. Wang, H., Hughes, I., Planer, W., Parsadanian, A., Grider, J.R., Vohra, B.P.S., Keller-Peck, C., Heuckeroth, R.O., The timing and location of glial cell line-derived neurotrophic factor expression determine enteric nervous system structure and function. J. Neurosci. 30 (2010), 1523–1538.
146. Wang, X., Hou, Z., Yuan, Y., Hou, G., Liu, Y., Li, H., Zhang, Z., Association study between plasma GDNF and cognitive function in late-onset depression. J. Affect. Disord. 132 (2011), 418–421.
147. Williams, H.J., Norton, N., Peirce, T., Dwyer, S., Williams, N.M., Moskvina, V., Owen, M.J., O'Donovan, M.C., Association analysis of the glial cell line-derived neurotrophic factor (GDNF) gene in schizophrenia. Schizophr. Res. 97 (2007), 271–276.
148. Winkler, C., Sauer, H., Lee, C.S., Bjorklund, A., Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 16 (1996), 7206–7215.
149. Wöhr, M., Orduz, D., Gregory, P., Moreno, H., Khan, U., Vörckel, K.J., Wolfer, D.P., Welzl, H., Gall, D., Schiffmann, S.N., et al. Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities. Transl. Psychiatry, 5, 2015, e525.
150. Yosef, N., Ubogu, E.E., GDNF restores human blood–nerve barrier function via RET tyrosine kinase-mediated cytoskeletal reorganization. Microvasc. Res. 83 (2012), 298–310.
151. Young, H., GDNF Is a chemoattractant for enteric neural cells. Dev. Biol. 229 (2001), 503–516.
152. Zahavi, E.E., Ionescu, A., Gluska, S., Gradus, T., Ben-Yaakov, K., Perlson, E., A compartmentalized microfluidic neuromuscular co-culture system reveals spatial aspects of GDNF functions. J. Cell Sci. 128 (2015), 1241–1252.
153. Zhu, S., Zhao, C., Wu, Y., Yang, Q., Shao, A., Wang, T., Wu, J., Yin, Y., Li, Y., Hou, J., et al. Identification of a Vav2-dependent mechanism for GDNF/Ret control of mesolimbic DAT trafficking. Nat. Neurosci. 18 (2015), 1084–1093.